Advocacy

Advocacy
Priorities

Ensuring access to mental health and addiction treatment and recovery services could not be more urgent or important than at this time. A report by the Centers for Disease Control and Prevention reported that symptoms of anxiety disorder were approximately three times higher and prevalence of depression about four times higher among adults during the second quarter of 2020 compared with the same period in 2019.

Meanwhile, overdoses have spiked during the Covid-19 pandemic with more than 40 states reporting increased opioid-related deaths, and an overall increase in overdoses of 18% between May of 2019 and 2020. At the same time, suicide rates have continued to rise, up 35% between 1999 and 2018, with early indications of additional increases in suicides more recently.

Our Covid-19 webpage is designed to help NABH members access important and applicable resources as they navigate the Covid-19 pandemic.

Removing Barriers to Care

Congress should eliminate outdated federal rules blocking access to cost-effective treatments.

Combating the SUD Crisis

Congress should increase access to substance use disorder treatment.

Expanding the Behavioral Health Workforce

Congress should expand the mental health and substance use disorder workforce.

CEO Update

  • CEO Update 194

    House Passes Bill to Reauthorize Child Welfare Programs Included RTF Provision The House Ways and Means Committee on Thursday passed unanimously H.R. 9076, the Bipartisan Protecting America’s Children by Strengthening Families Act, to reauthorize and reform the nation’s child welfare programs under Title IV-B of the Social Security Act. Authorization for these programs expired in fiscal ...
    Read more
  • CEO Update 193

    FDA & FTC Issue Warnings to Crack Down on Illegal Sales of Food Products with Delta-8 THC The Food and Drug Administration (FDA) and the Federal Trade Commission this week issued warnings to five companies to crack down on illegal sales of food products containing delta-8 THC. The products’ packaging resemble familiar snacks and candies, potentially leading ...
    Read more
  • CEO Update 192

    FDA Releases Guidance on Constructing Effective Clinical Trials for Devices The FDA on Thursday issued guidance about constructing effective clinical trials to develop medical devices that treat patients who misuse opioids. The new guidance is intended to improve both the design and development of clinical studies to provide a reasonable assurance of safety and effectiveness for a device ...
    Read more
  • CEO Update 191

    House Ways and Means Committee Hearing Examines U.S. Child Welfare System and RTFs The House Ways and Means Committee on Wednesday held a hearing about strengthening America’s child welfare system and protecting America’s children through reauthorizing Title IV-B, a child and youth foster-care program. Although committee members focused primarily on improving the nation’s child foster care system, ...
    Read more

Latest Content

CMS’ Proposed 2025 PFS Rule Would Cut Overall Payments by 2.8%

CMS’ Proposed 2025 PFS Rule Would Cut Overall Payments by 2.8% In its proposed rule for the calendar year (CY) 2025 physician fee schedule, the Centers for Medicare & Medicaid Services recommends reducing the conversion factor by 2.8% to $32.36…

Read more

CMS Updates IOP and PHP Payment Rates for 2025

CMS Updates IOP and PHP Payment Rates for 2025 The Centers for Medicare & Medicaid Services (CMS) today issued its calendar year (CY) 2025 Medicare hospital outpatient prospective payment system (OPPS) proposed rule, which proposes a net increase of 2.3…

Read more

NABH Comments on the Critical Role of Youth Residential Treatment Facilities

NABH Comments on the Critical Role of Youth Residential Treatment Facilities

Read more

The National Association for Behavioral Healthcare, are the people on the front lines of this fight…

U.S. Rep. Greg Walden
Chairman of the House Committee on Energy and Commerce

The Future of Behavioral Healthcare